Vinpocetine inhibits proliferation and induces apoptosis in human colon cancer cells

키워드

참고문헌 (30)

1. Iqbal S, "Integration of novel agents in the treatment of colorectal cancer", Cancer Chemother Pharmacol, 54(Suppl 1), pp.S32~S39 (2004)[DOI]
2. Zhang YS, "An update on vinpocetine : new discoveries and clinical implications", Eur J Pharmacol, 819, pp.30~34 (2018)[DOI]
3. Patyar S, "Role of vinpocetine in cerebrovascular diseases", Pharmacol Rep, 63, pp.618~628 (2011)[DOI]
4. Dézsi L, "Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke", Acta Pharm Hung, 72, pp.84~91 (2002)
5. Szilágyi G, "Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients : a PET study", J Neurol Sci, 229-230, pp.275~284 (2005)[DOI]
6. Hagiwara M, "Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle", Biochem Pharmacol, 33, pp.453~457 (1984)[DOI]
7. Truss MC, "Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro", Urol Res, 24, pp.129~134 (1996)[DOI]
8. Bönöczk P, "Role of sodium channel inhibition in neuroprotection : effect of vinpocetine", Brain Res Bull, 53, pp.245~254 (2000)[DOI]
9. Sitges M, "Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes", Neurochem Int, 46, pp.533~540 (2005)[DOI]
10. Giachini FR, "Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats : role of phosphodiesterase 1", Hypertension, 57, pp.655~663 (2011)[DOI]
11. Wu MP, "Vinpocetine attenuates pathological cardiac remodeling by inhibiting cardiac hypertrophy and fibrosis", Cardiovasc Drugs Ther, 31, pp.157~166 (2017)[DOI]
12. Colombo BB, "Vinpocetine ameliorates acetic acid-induced colitis by inhibiting NF-κB activation in mice", Inflammation, 41, pp.1276~1289 (2018)[DOI]
13. Jeon KI, "Vinpocetine inhibits NF-kappaBdependent inflammation via an IKK-dependent but PDEindependent mechanism", Proc Natl Acad Sci U S A, 107, pp.9795~9800 (2010)[DOI]
14. Huang EW, "Vinpocetine inhibits breast cancer cells growth in vitro and in vivo", Apoptosis, 17, pp.1120~1130 (2012)[DOI]
15. Ahn HS, "Calcium-calmodulinstimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels", Adv Second Messenger Phosphoprotein Res, 25, pp.271~288 (1992)
16. Kaneko S, "The use of Xenopus oocytes to evaluate drugs affecting brain Ca2+ channels : effects of bifemelane and several nootropic agents", Eur J Pharmacol, 189, pp.51~58 (1990)[DOI]
17. Erdo SA, "Vincamine and vincanol are potent blockers of voltage-gated Na+channels", Eur J Pharmacol, 314, pp.69~73 (1996)[DOI]
18. Nagel DJ, "Role of nuclear Ca2+", calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival, 2006, pp.98, 777~784
19. Dunkern TR, "Characterization of inhibitors of phosphodiesterase 1C on a human cellular system", FEBS J, 274, pp.4812~4824 (2007)[DOI]
20. Mehta A, "Therapeutic opportunities in colon cancer : focus on phosphodiesterase inhibitors", Life Sci, 230, pp.150~161 (2019)[DOI]
21. Sengupta R, "Treating brain tumors with PDE4 inhibitors", Trends Pharmacol Sci, 32, pp.337~344 (2011)[DOI]
22. Korniluk A, "From inflammation to cancer", Ir J Med Sci, 186, pp.57~62 (2017)[DOI]
23. Balkwill FR, "Cancer-related inflammation : common themes and therapeutic opportunities", Semin Cancer Biol, 22, pp.33~40 (2012)[DOI]
24. de Visser KE, "De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent", Cancer Cell, 7, pp.411~423 (2005)[DOI]
25. Rebouissou S, "Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours", Nature, 457, pp.200~204 (2009)[DOI]
26. Luo JL, "Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin", Nature, 446, pp.690~694 (2007)[DOI]
27. Fernandes JV, "The role of the mediators of inflammation in cancer development", Pathol Oncol Res, 21, pp.527~534 (2015)[DOI]
28. Medina AE, "Vinpocetine as a potent antiinflammatory agent", Proc Natl Acad Sci U S A, 107, pp.9921~9922 (2010)[DOI]
29. Karin M, "Nuclear factor-kappaB in cancer development and progression", Nature, 441, pp.431~436 (2006)[DOI]
30. Karin M, "NF-kappaB : linking inflammation and immunity to cancer development and progression", Nat Rev Immunol, 5, pp.749~759 (2005)[DOI]

관련 논문AI추천